Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Nanobiosym CEO Dr. Anita Goel and Former UK PM Tony Blair Tackle Global Challenges at Novartis Forum

Abstract:
Nanobiosym® Chairman and CEO Dr. Anita Goel, MD, PhD and Former UK Prime Minister Tony Blair delivered keynote addresses at the annual Novartis Forum for Excellence in Spain on June 2, 2011. Mr. Blair outlined five key challenges facing our planet today, while Dr. Goel unveiled game-changing nanotechnology solutions in development by Nanobiosym to address the most pressing global challenges in healthcare, energy and the environment.

Nanobiosym CEO Dr. Anita Goel and Former UK PM Tony Blair Tackle Global Challenges at Novartis Forum

Madrid, Spain | Posted on June 8th, 2011

The Novartis Forum for Excellence exemplifies the Novartis commitment to research, development, and commercialization of innovation and excellence in business. According to Francisco Ballester, CEO of Novartis Pharmaceuticals, "Innovation and commitment will always come with leadership. These leaders have a visionary, different attitude and ideas that shine." Times of great uncertainty demand leaders that can articulate a clear vision for the future. One that defines us, unites us and inspires us. This fourth Novartis forum was held in the framework of ExpoManagement, the largest management conference in Spain where elite business leaders gather to discuss the latest challenges and innovations in science, technology and social responsibility.

Considered one of the world's most influential global leaders, Mr. Blair addressed the key challenges facing the world today, including, managing the new interdependent global economy, energy supply security, peace in the Middle East, a new direction for Europe and the emergence of China. Mr. Blair highlighted the need for leadership in science and technology to accelerate sustainable development across the globe.

One of the world's top science and technology innovators, Dr. Anita Goel showcased nanotechnology-enabled solutions that she and Nanobiosym are developing to address some of the most pressing global challenges. A Harvard-MIT trained physicist and physician, and an internationally recognized nanotechnology expert and entrepreneur, Dr. Goel unveiled some of Nanobiosym's breakthrough technologies like Gene-RADAR®, a nanotechnology device platform that reduces the infrastructure required for diagnosing diseases from a centralized pathology lab to a mobile device much like a cellphone. She invited the audience to join the Nanobiosym Global Innovation Ecosystem to help scale up these game-changing technologies and collectively tackle the largest problems facing our planet today. "I believe that science and technology alone, no matter how game-changing, are not enough. We need to raise the consciousness with which we deploy these technologies across the globe." She also outlined a roadmap to harness nanotechnology to drive the new global economy defining key leadership roles that Europe and the United States, as well as emerging economies can play.

Inspired by the underlying unity of nature, Dr. Goel embarked upon a quest over 15 years ago to bring the worlds of physics and biomedicine together using nanotechnology - the ability to probe and control nature at very small scales- less than a billionth of a meter. "We already have the tools within science and technology to address many of the world's problems today such as access to healthcare, sustainable supplies of energy, food and water." Dr. Goel urged the need for a more holistic approach that transcends the conventional boundaries between various fields of science, technology, industries and geopolitics, enabling new quantum leaps in how we solve global problems.

####

About Nanobiosym
Nanobiosym® (NBS) is an innovation engine dedicated to creating a new science that emerges from the holistic integration of physics, biomedicine, and nanotechnology. NBS focuses on incubating transformational technologies that have the potential for game-changing impact and commercializing and scaling up these technologies for deployment in developed and developing world markets. NBS leverages science and technology to address our planet’s greatest unmet needs in global health, energy and the environment. Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of the Gene-RADAR®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health.To maximize global humanitarian impact, Dr. Goel has spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.

For more information, please click here

Contacts:
Judith Light Feather
President
The NanoTechnology Group Inc.
Cell: 936-652-3006
www.TNTG.org
www.NanoNEWS.TV

Copyright © Nanobiosym

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

Next-gen solar cells spin in new direction: Phosphorene shows efficiency promise June 21st, 2019

Researchers report new understanding of thermoelectric materials: Discovery leads to promising new materials for converting waste heat to power June 21st, 2019

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

Nanomedicine

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

'Nanoemulsion' gels offer new way to deliver drugs through the skin: Novel materials made with FDA-approved components could deliver large payloads of active ingredients June 21st, 2019

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3 June 21st, 2019

Announcements

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

Ice lithography: opportunities and challenges in 3D nanofabrication June 21st, 2019

Researchers report new understanding of thermoelectric materials: Discovery leads to promising new materials for converting waste heat to power June 21st, 2019

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

Environment

Good vibrations: Using piezoelectricity to ensure hydrogen sensor sensitivity May 24th, 2019

New surface treatment could improve refrigeration efficiency: A slippery surface for liquids with very low surface tension promotes droplet formation, facilitating heat transfer May 17th, 2019

Better microring sensors for optical applications May 10th, 2019

Transforming waste heat into clean energy: Researchers use supercomputers to explore new materials for thermoelectric generation May 2nd, 2019

Energy

Next-gen solar cells spin in new direction: Phosphorene shows efficiency promise June 21st, 2019

Researchers report new understanding of thermoelectric materials: Discovery leads to promising new materials for converting waste heat to power June 21st, 2019

'Hot spots' increase efficiency of solar desalination: Rice University engineers boost output of solar desalination system by 50% June 19th, 2019

UCI scientists create new class of two-dimensional materials: Fabrication could help unlock new quantum computing and energy technologies June 6th, 2019

Events/Classes

Arrowhead Pharmaceuticals to Present at Upcoming June 2019 Conferences June 2nd, 2019

ACS selects Naomi Halas to represent Americas at ChinaNano: Rice U. pioneer wins 2019 ACS Nano Lectureship Award for the Americas May 29th, 2019

CEA-Leti Develops CMOS Process for High-Performance MicroLEDs That Could Overcome Display-Size Obstacles: New Concept Creates All-in-One RGB MicroLEDs, Eliminates Several Transfer Steps to Receiving Substrate & Boosts Performance May 16th, 2019

Arrowhead Pharmaceuticals to Present at Upcoming May 2019 Conferences May 3rd, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project